The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 31, 2020

Filed:

Aug. 20, 2009
Applicants:

John C. Bell, Ottawa, CA;

Fabrice Le Boeuf, Ottawa, CA;

Inventors:

John C. Bell, Ottawa, CA;

Fabrice Le Boeuf, Ottawa, CA;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/16 (2006.01); A61K 35/766 (2015.01); A61K 35/768 (2015.01); A61K 38/19 (2006.01); A61K 35/76 (2015.01);
U.S. Cl.
CPC ...
A61K 38/162 (2013.01); A61K 35/76 (2013.01); A61K 35/766 (2013.01); A61K 38/193 (2013.01); C12N 2710/24132 (2013.01); C12N 2760/20232 (2013.01);
Abstract

In one aspect, the invention provides methods for preferentially killing target proliferating cells in a host, such as cancer cells, by infecting host tissues with two or more strains of virus. The strains of virus may be selected to provide a synergistic and symbiotic effect, involving a contemporaneous lytic infection in the target proliferating cells. In selected embodiments, the viruses are selected so that expression of a first virulence factor in proliferating cells infected with the first virus increases the lytic effect of the second virus; and, expression of the second virulence factor in proliferating cells infected with the second virus increases the lytic effect of the first virus. The genomes of the first and second viruses may be selected so that they are incompatible for recombination between the viral genomes in cells of the host.


Find Patent Forward Citations

Loading…